ArfGAP with GTPase Domain, Ankyrin Repeat and PH Domain 3 (AGAP3) Peptide
-
- Target See all AGAP3 products
- AGAP3 (ArfGAP with GTPase Domain, Ankyrin Repeat and PH Domain 3 (AGAP3))
- Origin
- Human, Mouse, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- NPSAELHRSP SLL
- Characteristics
- The peptide was used in the production of ABIN369489 - Goat Anti-CENTG3 / MRIP1 Antibody. It is currently untested in blocking applications.
-
-
- Application Notes
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- AGAP3 (ArfGAP with GTPase Domain, Ankyrin Repeat and PH Domain 3 (AGAP3))
- Synonyms
- CENTG3 Peptide, AGAP-3 Peptide, CRAG Peptide, MRIP-1 Peptide, cnt-g3 Peptide, AV028425 Peptide, Centg3 Peptide, Crag Peptide, Crag. Peptide, ArfGAP with GTPase domain, ankyrin repeat and PH domain 3 Peptide, AGAP3 Peptide, Agap3 Peptide
-